Sunesis Pharmaceuticals Announces Withdrawal of European MAA for Vosaroxin as a Treatment for Relapsed/Refractory AML Read more
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer’s Disease Read more
GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD Read more
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications Read more